Clinical Trial Update: ALK21-006EXT: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol- or Opioid-dependent Adults (Extension of Study ALK21-006 [NCT01218997]) [Phase 3]

View source ↗

Summary

This is a long-term safety extension of a Phase 3 study evaluating VIVITROL (naltrexone extended-release) for alcohol and opioid dependence, which was terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Opioid Use Disorder

Drugs mentioned

• Vivitrol (naltrexone extended-release injectable)

Snippet

Sponsor: Alkermes, Inc. | Conditions: Alcoholism, Opiate Dependence | Phase 3 | Status: TERMINATED | Results posted: 2010-11-03